Laryngeal squamous cell carcinoma
MONDO:0005595A squamous cell carcinoma that arises from the larynx. It is the most common histologic type of laryngeal carcinoma. It can arise from the glottis, supraglottic area, or it can be transglottic. Glottic squamous cell carcinoma is the most frequent laryngeal carcinoma in the United States. The symptoms, clinical behavior and the prognosis depend on the site of origin within the larynx.
Also known as: epidermoid carcinoma of larynx, epidermoid carcinoma of the larynx, laryngeal epidermoid carcinoma, laryngeal squamous cell carcinoma, laryngeal throat squamous cell cancer, larynx epidermoid carcinoma, larynx squamous cell carcinoma, squamous cell carcinoma of larynx
2925 clinical trials for this condition and its sub-types, 72 tagged with Laryngeal squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Laryngeal squamous cell carcinoma
-
Glottis squamous cell carcinoma 5 trials
1 sub-type
- Glottis verrucous carcinoma 0 trials
-
Larynx verrucous carcinoma 2 trials
3 sub-types
- Glottis verrucous carcinoma 0 trials
- Subglottis verrucous carcinoma 0 trials
- Supraglottis verrucous carcinoma 0 trials
-
1 sub-type
- Supraglottis verrucous carcinoma 0 trials
-
Subglottis squamous cell carcinoma 0 trials
1 sub-type
- Subglottis verrucous carcinoma 0 trials
-
New combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether giving a combination of the immunotherapy drug camrelizumab and two chemotherapy drugs (paclitaxel and carboplatin) before surgery can improve outcomes for people with advanced oral cavity or larynx cancer. Fifty participants will receive three cy…
Phase 2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can planned IV fluids tame the brutal side effects of head and neck cancer treatment?
Symptom relief Not yet recruitingThis trial tests whether giving IV fluids on a fixed schedule during chemoradiation for head and neck cancer can reduce severe side effects like mouth sores, swallowing problems, and kidney injury. Half of the participants will receive IV fluids twice a week starting in week 3 of…
Sponsor: West Virginia University • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New study aims to understand laryngeal cancer Patients' recovery journey
Knowledge-focused Not yet recruitingThis study follows 120 people with laryngeal cancer to see how their quality of life, voice, swallowing, pain, and mood change before treatment and at 3, 6, and 12 months after. Researchers will use questionnaires to track these changes. The goal is to better understand recovery …
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC